GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | -10.1% | 41,326 | +2.3% | 0.00% | – |
| Q2 2023 | $79 | -92.1% | 40,400 | +9802.0% | 0.00% | – |
| Q2 2022 | $1,000 | -98.9% | 408 | -98.2% | 0.00% | – |
| Q1 2022 | $95,000 | -67.9% | 23,108 | +0.3% | 0.00% | – |
| Q4 2021 | $296,000 | +18.4% | 23,036 | -0.5% | 0.00% | – |
| Q3 2021 | $250,000 | +11.1% | 23,161 | -6.1% | 0.00% | – |
| Q2 2021 | $225,000 | -2.2% | 24,654 | +1.0% | 0.00% | – |
| Q1 2021 | $230,000 | +259.4% | 24,400 | +50.6% | 0.00% | – |
| Q4 2020 | $64,000 | +48.8% | 16,200 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | -60.2% | 16,200 | 0.0% | 0.00% | – |
| Q2 2020 | $108,000 | +14.9% | 16,200 | 0.0% | 0.00% | – |
| Q1 2020 | $94,000 | -35.2% | 16,200 | 0.0% | 0.00% | – |
| Q4 2019 | $145,000 | -34.1% | 16,200 | -36.5% | 0.00% | – |
| Q3 2019 | $220,000 | -22.5% | 25,500 | 0.0% | 0.00% | – |
| Q2 2019 | $284,000 | +435.8% | 25,500 | +537.5% | 0.00% | – |
| Q1 2019 | $53,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |